H-VLDVGDAYFSV-OH
Ref. 3D-PP42880
1mg | 248,00 € | ||
10mg | 292,00 € | ||
100mg | 481,00 € |
Produktinformation
- NH2-Val-Leu-Asp-Val-Gly-Asp-Ala-Tyr-Phe-Ser-Val-OH
Peptide H-VLDVGDAYFSV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLDVGDAYFSV-OH include the following: Quantification of CD8+ T Lymphocytes Responsive to Human Immunodeficiency Virus (HIV) Peptide Antigens in HIV-Infected Patients and Seronegative Persons at W Herr, U Protzer , AW Lohse, G Gerken - Journal of Infectious , 1998 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/178/1/260/919828 Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase SH van der Burg , MR Klein , CJH van de Velde - Aids, 1995 - journals.lww.comhttps://journals.lww.com/aidsonline/abstract/1995/02000/Induction_of_a_primary_human_cytotoxic.2.aspx Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. SH Van Der Burg , MJ Visseren, RM Brandt - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/156/9/3308/29478 Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients C Shiu, CK Cunningham , T Greenough - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00570-09
Chemische Eigenschaften
Technische Anfrage zu: 3D-PP42880 H-VLDVGDAYFSV-OH
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.